Eli Lilly | Capitalização De Mercado



Market Capitalization Alterar Data
AbbVie USD 314.02B 34.8B 2024-12
Abbott USD 196.18B 2.18B 2024-12
ALKERMES USD 4.65B 123M 2024-12
Amgen USD 140.1B 33.03B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Baxter International USD 14.88B 4.49B 2024-12
Biogen USD 22.28B 5.95B 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Drreddys Laboratories USD 13.43B 639M 2024-09
Eli Lilly USD 732.87B 109.15B 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
Glaxosmithkline USD 82.81B 2.66B 2024-09
Indivior 1.28B 325.08M 2024-12
J&J USD 348.19B 41.93B 2024-12
Medtronic USD 102.43B 13.03B 2024-12
Merck USD 251.65B 36.21B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Novartis USD 230.87B 3.48B 2024-09
Novo Nordisk A/S 2.12T 551.23B 2024-12
Perrigo USD 3.51B 70M 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Prestige Brands USD 3.86B 285M 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Sanofi EUR 118.41B 10.58B 2024-12
Sanofi USD 145.36B 23.34B 2024-09
United Therapeutics USD 15.75B 191M 2024-12
Zoetis USD 73.51B 15.01B 2024-12



Eli Lilly Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.